Skip to main content
ARS Home » Plains Area » Houston, Texas » Children's Nutrition Research Center » Research » Publications at this Location » Publication #319309
Title: Commentary: Launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype

Author
item ROSENFIELD, ROBERT - University Of Chicago
item DIMEGLIO, LINDA - Indiana University School Of Medicine
item MAURAS, NELLY - Nemours Children'S Clinic
item ROSS, JUDITH - Thomas Jefferson University
item SHAW, NATALIE - Massachusetts General Hospital
item GREELEY, SIRI - University Of Chicago
item HAYMOND, MOREY - Children'S Nutrition Research Center (CNRC)
item RUBIN, KAREN - University Of Connecticut
item RHODES, ERINN - Boston Children'S Hospital

Submitted to: Journal of Clinical Endocrinology and Metabolism
Publication Type: Review Article
Publication Acceptance Date: 10/21/2014
Publication Date: 4/1/2015
Citation: Rosenfield, R.L., Dimeglio, L.A., Mauras, N., Ross, J., Shaw, N.D., Greeley, S.A., Haymond, M.W., Rubin, K., Rhodes, E.T. 2015. Commentary: Launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype. Journal of Clinical Endocrinology and Metabolism. 100(4):1234-1236.

Interpretive Summary:

Technical Abstract: Traditional, hypothesis-oriented research approaches have thus far failed to generate sufficient evidence to achieve consensus about the management of children with many endocrine disorders, partly because of the rarity of these disorders and because of regulatory burdens unique to research in children. The Pediatric Endocrine Society is launching a quality improvement network in spring 2015 for the management of pediatric endocrine disorders that are relatively uncommon in any single practice and/or for which there is no consensus on management. The first of the quality improvement programs to be implemented seeks to improve the care of 11- to 17-year-old girls with Turner syndrome who require initiation of estrogen replacement therapy by providing a standardized clinical assessment and management plan (SCAMP) for transdermal estradiol treatment to induce pubertal development. The SCAMP algorithm represents a starting point within current best practice that is meant to undergo refinement through an iterative process of analysis of deidentified data collected in the course of clinical care by a network of pediatric endocrinologists. It is anticipated that this program will not only improve care, but will also result in actionable data that will generate new research hypotheses and changes in management of pediatric endocrine disorders.